BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Conditions:   Bronchiolitis Obliterans Syndrome;   Bronchiolitis Obliterans;   Lung Diseases;   Chronic Graft Versus Host Disease Interventions:   Drug: Belumosudil;   Drug: Fluticasone;   Drug: Azithromycin;   Drug: Prednisone Sponsors:   Dana-Farber Cancer Institute;   Sanofi;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials